Protia Inc. (KOSDAQ:303360)
South Korea · Delayed Price · Currency is KRW 5,090.00
-300.00 (-5.57%)
At close: Jan 30, 2026
Protia Company Description
Protia Inc. manufactures and sells in vitro diagnostic medical devices in South Korea.
It offers allergy, animal diagnosis, autoimmune, antibiotic susceptibility, POCT, cancer, and related instrument products, as well as protein analysis, LC-MS/MS, characterization analysis, and custom protein services.
The company was formerly known as ProteomeTech Inc. and changed its name to Protia Inc. in November 2023.
Protia Inc. was founded in 2000 and is headquartered in Seoul, South Korea.
Protia Inc.
| Country | South Korea |
| Founded | 2000 |
| Industry | In Vitro and In Vivo Diagnostic Substances |
| CEO | Kook Jin Lim |
Contact Details
Address: A-702, 401 Yangcheon-ro Seoul, 07528 South Korea | |
| Phone | 82 2 6968 5288 |
| Website | protia.co.kr |
Stock Details
| Ticker Symbol | 303360 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Kook Jin Lim | Chief Executive Officer |